The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
A severe storm has caused flash flooding in the popular Spanish holiday resort of Malaga.
NHS trusts in England reported a third-quarter year-end deficit of £886 million against a target year-end deficit of £580 million.
Former Leeds United starlet Elliot Kebbie is now starting his career once again, at the age of 22, after years of setbacks.